Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course

Blood. 2002 Aug 1;100(3):1106. doi: 10.1182/blood-2002-04-1287.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • ADP-ribosyl Cyclase
  • ADP-ribosyl Cyclase 1
  • Antigens, CD*
  • Antigens, Differentiation / metabolism*
  • Biomarkers, Tumor / immunology
  • Biomarkers, Tumor / metabolism
  • Bone Marrow Cells / immunology
  • Bone Marrow Cells / pathology
  • Disease Progression
  • Humans
  • Leukemia, B-Cell / diagnosis
  • Leukemia, B-Cell / immunology
  • Leukemia, B-Cell / metabolism*
  • Membrane Glycoproteins
  • Myeloid Cells / immunology
  • Myeloid Cells / pathology
  • NAD+ Nucleosidase / metabolism*
  • Prognosis

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • Biomarkers, Tumor
  • Membrane Glycoproteins
  • ADP-ribosyl Cyclase
  • CD38 protein, human
  • NAD+ Nucleosidase
  • ADP-ribosyl Cyclase 1